EEG ALTERATIONS IN PATIENTS TREATED WITH CLOZAPINE IN RELATION TO PLASMA-LEVELS

被引:70
作者
HARING, C
NEUDORFER, C
SCHWITZER, J
HUMMER, M
SARIA, A
HINTERHUBER, H
FLEISCHHACKER, WW
机构
[1] UNIV INNSBRUCK CLIN, DEPT PSYCHIAT, ELECTROPHYSIOL UNIT, A-6020 INNSBRUCK, AUSTRIA
[2] UNIV INNSBRUCK CLIN, DEPT PSYCHIAT, NEUROCHEM UNIT, A-6020 INNSBRUCK, AUSTRIA
关键词
CLOZAPINE; PLASMA LEVEL; EEG ANTIPSYCHOTICS;
D O I
10.1007/BF02245449
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It is well known that psychotropic drugs can induce EEG alterations. Dose dependence seems established; however, there are no data concerning the impact of plasma levels. The authors investigated the influence of clozapine plasma levels on the frequency of EEG alterations. Data from 29 inpatients (18 male, 11 female, 31.7 +/- 10.2 years) receiving clozapine in a dose range between 25 and 600 mg were collected prospectively. There was no psychotropic or anticholinergic comedication. All patients had normal EEGs before taking clozapine. Fifteen patients showed pathological changes (group 2) and 14 no changes (group 1). Discriminant analysis showed that EEG changes are dependent on plasma levels (P = 0.0009, plasma levels in group 1 mean 81.6 ng/ml, +/- SD 64.6, in group 2 235.7 ng/ml, +/- 169.8). A total of 72.4% of the patients were correctly classified as having either pathological EEG changes or none by this analysis. Variables such as dose, age, sex, weight and duration of treatment were not statistically relevant. It can therefore be suggested that clozapine plasma levels are a valid indicator for the appearance of electrophysiological reactions.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 19 条
[1]   EEG PROFILE STUDIES OF CLOZAPINE IN VOLUNTEERS AND PSYCHIATRIC-PATIENTS [J].
FINK, M ;
IRWIN, P ;
WEINHOLD, P .
PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1979, 12 (02) :184-190
[2]   CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC USE IN SCHIZOPHRENIA [J].
FITTON, A ;
HEEL, RC .
DRUGS, 1990, 40 (05) :727-747
[3]  
HALLER E, 1990, AM J PSYCHIAT, V147, P1069
[4]   CLOZAPINE PLASMA-LEVELS DETERMINED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
HARING, C ;
HUMPEL, C ;
AUER, B ;
SARIA, A ;
BARNAS, C ;
FLEISCHHACKER, W ;
HINTERHUBER, H .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 428 (01) :160-166
[5]  
HARING C, 1990, AM J PSYCHIAT, V147, P1471
[6]  
ISERMANN H, 1976, NERVENARZT, V47, P268
[7]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[8]   PAROXYSMAL EEG ACTIVITY AND PSYCHOPATHOLOGY DURING THE TREATMENT WITH CLOZAPINE [J].
KOUKKOU, M ;
ANGST, J ;
ZIMMER, D .
PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1979, 12 (02) :173-183
[9]   LEPONEX - ASSOCIATED GRANULOCYTOPENIA - A REVIEW OF THE SITUATION [J].
KRUPP, P ;
BARNES, P .
PSYCHOPHARMACOLOGY, 1989, 99 :S118-S121
[10]   DRUG-INDUCED PAROXYSMAL EEG-ACTIVITIES [J].
KUGLER, J ;
LORENZI, E ;
SPATZ, R ;
ZIMMERMANN, H .
PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1979, 12 (02) :165-172